MedPath
NMPA Approval

Doxofylline Injection

国药准字H20234452

October 30, 2023

Drug Information

多索茶碱注射液

注射剂

10ml:0.1g

化学药品

October 30, 2023

Company Information

Applicant Company

浙江省东阳市江北高科技工业园区

Manufacturing Company

浙江省东阳市江北高科技工业园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

多索茶碱注射液 - NMPA 批准文号 | MedPath